Synthetic miR-145 Mimic Enhances the Cytotoxic Effect of the Antiangiogenic Drug Sunitinib in Glioblastoma (Q38922566)

7 September 2017

title

Synthetic miR-145 Mimic Enhances the Cytotoxic Effect of the Antiangiogenic Drug Sunitinib in Glioblastoma (English)

1 reference

7 September 2017

main subject

angiogenesis inhibitor

1 reference

Hongwei Liu

1

1 reference

7 September 2017

Zhixiong Liu

2

1 reference

7 September 2017

Bing Jiang

3

1 reference

7 September 2017

Lei Huo

4

1 reference

7 September 2017

Jinfang Liu

5

1 reference

7 September 2017

Jingchen Lu

6

1 reference

7 September 2017

publication date

7 January 2015

1 reference

Cell Biochemistry and Biophysics

7 September 2017

published in

1 reference

7 September 2017

volume

72

1 reference

7 September 2017

issue

2

1 reference

7 September 2017

page(s)

551-557

1 reference

Malignant astrocytic glioma: genetics, biology, and paths to treatment

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Molecular advances of brain tumors in radiation oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Chemotherapy and novel therapeutic approaches in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Angiogenesis in malignant glioma--a target for antitumor therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Pathway inhibition: emerging molecular targets for treating glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

MicroRNA functions in animal development and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Emerging functions of microRNAs in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

A Developmental Taxonomy of Glioblastoma Defined and Maintained by MicroRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Growth inhibition by microRNAs that target the insulin receptor substrate-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Gene regulation by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

MicroRNAs in the Pathogenesis of Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Platelet-derived growth factor in human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Sunitinib in metastatic renal cell carcinoma patients with brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

Pharmacokinetic assessment of efflux transport in sunitinib distribution to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12013-014-0501-8

10.1007/S12013-014-0501-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1033257508

0 references

1 reference